Skip to main content

CalciMedica, Inc.

CALC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001534133

No open-market purchases or sales by CalciMedica, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $8.39M in total; no superinvestor holds it.

Q2 2022 vs. Q1 2022

How the institutions holding CalciMedica, Inc. changed between Q1 2022 and Q2 2022.

All holders in Q2 2022All holders in Q1 2022

13F holders of CALC: Q1 2022 compared with Q2 2022
MeasureQ1 2022Q2 2022Change
Holders2725−2
Shares11.0M10.7M−222.0K (−2.0%)
Value$13.5M$11.7M−$1.76M (−13.1%)

New holders (4)

Institutions that held CalciMedica, Inc. at the end of Q2 2022 but not at the end of Q1 2022.

Institutions new to CALC in Q2 2022
InstitutionSharesValue% of portfolio
Levin Capital Strategies, L.P.15,000$16.0K0.00%
Susquehanna International Group, LLP11,229$12.0K0.00%
The PNC Financial Services Group, Inc.8,612$9.00K0.00%
Simplex Trading, LLC216$00.00%

Sold out (6)

Institutions that held CalciMedica, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.

Institutions that sold out of CALC in Q2 2022
InstitutionShares, Q1 2022Value, Q1 2022
Citadel Advisors LLC51,605$63.0K
Group One Trading, L.P.2,462$3.00K
JPMorgan Chase & Co538$1.00K
Royal Bank of Canada1,000$1.00K
Citigroup Inc30$0
Tower Research Capital LLC (TRC)191$0